Last CNY32.92 CNY
Change Today -0.17 / -0.51%
Volume 2.1M
As of 2:00 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

boai nky pharmaceuticals-a (300109) Snapshot

Open
CNY32.86
Previous Close
CNY33.09
Day High
CNY33.55
Day Low
CNY32.86
52 Week High
12/5/14 - CNY37.18
52 Week Low
04/28/14 - CNY10.82
Market Cap
3.8B
Average Volume 10 Days
2.9M
EPS TTM
CNY0.18
Shares Outstanding
115.2M
EX-Date
06/11/14
P/E TM
182.9x
Dividend
CNY0.06
Dividend Yield
0.18%
Current Stock Chart for BOAI NKY PHARMACEUTICALS-A (300109)

Related News

No related news articles were found.

boai nky pharmaceuticals-a (300109) Related Businessweek News

No Related Businessweek News Found

boai nky pharmaceuticals-a (300109) Details

Boai NKY Pharmaceuticals Ltd. develops, manufactures, and sells polyvinylpyrrolidone (PVP) series products primarily in China. It offers povidone, crospovidone, copovidone, 2-pyrrolidone, PVP/H2O2 complexes, PVM/MA copolymers, OraRez MS, cross linked polyvinlypyrrolidone, N-vinylpyrrolidone, N-vinylcaprolactam, 1-vinylimidazole, 1,3-diethenyl-2-imidazolidinone, ethyl vinyl ether, n-butyl vinyl ether, isobutyl vinyl ether, and tert-butyl vinyl ether to pharmaceuticals, cosmetics, wine/beer/beverage, and other industries. The company is based in Jiaozuo, China.

boai nky pharmaceuticals-a (300109) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

boai nky pharmaceuticals-a (300109) Key Developments

Boai NKY Pharmaceuticals Ltd. Approves Amendments to Articles of Association

Boai NKY Pharmaceuticals Ltd. at the Extraordinary General Meeting of 2015 held on 16 January 2015, shareholders approved the amendments to the articles of association of the company.

Boai NKY Pharmaceuticals Ltd. Proposes Amendments to the Articles of Association

Boai NKY Pharmaceuticals Ltd. proposed amendments to the articles of association of the company at its first Extraordinary General Meeting of 2015 to be held on 16 January 2015.

Boai NKY Pharmaceuticals Ltd., Special/Extraordinary Shareholders Meeting, Jan 16, 2015

Boai NKY Pharmaceuticals Ltd., Special/Extraordinary Shareholders Meeting, Jan 16, 2015., at 13:30 China Standard Time. Agenda: To consider the eligibility for assets purchase via share offering and raising matching fund; to consider the restructuring constitutes connected transaction; to consider the restructuring is in compliance with the 2nd clause of 42nd article in the management measures on major assets restructuring of listed companies; to consider the restructuring is in compliance with the 4th article in the provisions on several issues concerning the regulation of major assets restructuring by listed companies; to sign conditional agreement on the assets purchase via share offering and share purchase agreement; to consider amendments to the articles of association of the company; to consider amendments to the company's rules of procedures governing shareholders' general meetings; to consider amendments to the raised fund management system; to consider the development strategy; and to consider amendments to implementation rules for online voting system at general meetings.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300109:CH CNY32.92 CNY -0.17

300109 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300109.
View Industry Companies
 

Industry Analysis

300109

Industry Average

Valuation 300109 Industry Range
Price/Earnings 100.0x
Price/Sales 15.6x
Price/Book 9.6x
Price/Cash Flow 137.3x
TEV/Sales 15.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOAI NKY PHARMACEUTICALS-A, please visit www.china-pvp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.